Business Standard

BDR Pharma prostate cancer drug at 1/3rd of innovator brand price

The price for a bottle of 60 tablets is Rs 22,500 and for a bottle of 120 tablets is Rs 45,000

Scientists find potential trigger to kill cancer
Premium

Sohini Das Mumbai
BDR Pharmaceutical launched the first generic of a key prostrate cancer drug – Apalutamide under the brand name Apatide in India at one-third the price of the innovator brand.

Raheel Shah, Director Business Development, BDR Group said that the product will be available across India in strengths of 60mg in packs of 60 tablets and 120 tablets. “Typically a patient is put on this drug for two months with a gap of one week in between the two months,” Shah said.

The price for a bottle of 60 tablets is Rs 22,500 and for a bottle of 120 tablets is

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in